MBRX

Moleculin Biotech (MBRX)

About Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Details

Daily high

$2.30

Daily low

$2.08

Price at open

$2.15

52 Week High

$33.00

52 Week Low

$1.79

Market cap

11.2M

Dividend yield

0.00%

Volume

122,190

Avg. volume

137,874

P/E ratio

-.05

Moleculin Biotech News